Human bodily fluids and secretions contain molecules known as biomarkers that contain a wealth of information about the body's health and the presence of disease. Among secretions such as tears, sweat and saliva, tears are considered the best source of biomarkers, with concentrations similar to those found in blood.
Tears are also sterile, readily available and less susceptible to the damaging effects of temperature change, evaporation and secretion rate.
Enlarged prototype of biosensor lens with reservoirs.
Products and exhibitors around diagnostics
Exhibitors and products related to this topic can be found in the catalogue of MEDICA 2020:
Useful and measurable biomarkers found in tears include sodium ions, which are useful indicators of dry-eye disease, and glucose molecules, an early diagnostic tool for diabetes. Also, measuring the pH of tears can be used to check for cell viability, drug effectiveness and for signs of disease.
Therefore, the ability to collect tears in an effective way and to measure their pH and levels of biomarkers in real-time is highly desirable. One approach that is actively being explored is the idea of contact lens biosensors. Such contact lenses could be designed to include tiny channels on their surfaces for guiding the flow of tears into tiny reservoirs for collection and monitoring.
A collaborative team, which includes a group from the Terasaki Institute for Biomedical Innovation, has developed a fabrication method to meet all the challenges in making a hydrogel contact lens for biomarker sensing. The team began by optimizing the components of the hydrogel to obtain elastic characteristics which would allow it to be engineered into various shapes with a smooth surface profile. They next fashioned microchannels in the hydrogel with the use of a 3D printed mold. The final step in the fabrication process was to enclose the hydrogel channels by bonding an additional layer of hydrogel onto the microchannel surface.
Once the successful prototype was completed, it was extensively tested for its performance in channeling and collecting fluids. Flow rates of artificial tears in the channels were measured at different levels of hydration, with zero flow measured at complete dehydration and full spontaneous flow observed at full hydration.
A noteworthy observation during these tests was that when the hydrogel was mildly dehydrated, liquid flow in the channels would stop, but when additional rhythmic pressure was applied, the flow would resume. This was an important demonstration of support for the hypothesis that eye blinking would also provide the necessary pressure and additional hydration needed to allow for tear flow in the contact lens, and therefore, in the eye.
"In addition to our successful fabrication of microchannels in commercial contact lens hydrogels, we also found that eye-blinking pressure may facilitate tear exchange in the lens through these microchannels, said Shiming Zhang, Ph.D., from the Terasaki Institute's research team. "This is an exciting finding because it opens the possibility for the lenses to be a means of preventing dry eye disease, a condition commonly found in contact lens wearers. We aim to develop a patented contact lens that actively treats this condition by enhancing tear flow in the eye."
The team next prototyped sensors to collect, test for and measure pH levels of artificial tears flowing through the microchannels. Sodium levels were also tested, and the results showed an acceptable and predicted range of sodium detection for diagnostic purposes.
Additional goals would be to fine-tune factors such as humidity, hydrogel hydration and applied pressure in order to enhance all the flow rates and dynamics of the biosensing contact lens.
"The production of the successful prototype described here and the continuing efforts to perfect its capabilities mark a significant advance in contact lens biosensing," said Ali Khademhosseini, Ph.D., director and CEO of the Terasaki Institute. "Such innovative work fits in well with our institute's mission to create solutions that restore or enhance the health of individuals."
MEDICA-tradefair.com; Source: Terasaki Institute for Biomedical Innovation